Affymax, Inc./ US00826A1097 /
07/06/2024 17:49:37 | Chg. 0.0000 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
0.0007USD | 0.00% | 200 Turnover: .1400 |
-Bid Size: - | -Ask Size: - | 0.0007 | 0.0007 |
GlobeNewswire
14/05
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
18/09/2023
AnaptysBio Announces Appointment of John Orwin as Chairman of the Board of Directors
GlobeNewswire
24/08/2023
CARGO Therapeutics Appoints Biotech Life Sciences Leaders to Board of Directors
GlobeNewswire
04/10/2021
Annexon Biosciences Further Strengthens Its Executive Leadership Team With Appointment of Ted Yednoc...
GlobeNewswire
02/02/2021
Protara Therapeutics Announces Appointment of Cynthia Smith to Board of Directors
GlobeNewswire
19/01/2021
T-knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis ...
GlobeNewswire
11/07/2019
Atreca Further Strengthens Management Team with Appointment of Lisa Decker as Chief Business Officer...
GlobeNewswire
14/05/2018
UNITY Biotechnology, Inc. Appoints Camille Landis as Senior Vice President of Corporate Development
GlobeNewswire
20/03/2018
Alder BioPharmaceuticals® Appoints Paul B. Cleveland as Interim President and Chief Executive Offic...
GlobeNewswire
12/03/2018
Assembly Biosciences Announces Additions to Management Team and Board of Directors
GlobeNewswire
05/01/2018
miRagen Therapeutics Expands Board of Directors with Appointment of Arlene Morris
GlobeNewswire
09/05/2017
Zosano Reports First Quarter 2017 Financial Results and Announces Management Changes
GlobeNewswire
04/11/2016
LifeSci Advisors’ Board Placement Initiative Announces Fifth Board Placement
GlobeNewswire
04/11/2016
LifeSci Advisors' Board Placement Initiative Announces Fifth Board Placement